Moderna Inc

Moderna Inc(MRNA)のニュースとイベント

$236.500

+10.666 (+4.51%)終値時点

MRNA のニュース

MRNA のイベント

10/9 16:30

Trump Says U.S. Will Not Strike Iran, Oil Pulls Back

Bets on a solid earnings season sent stocks to within striking distance of their all-time highs and oil pulled back as President Trump said that the U.S. will not resume military strikes against Iran before the November midterm elections. In addition, Trump said late in the session that Russian leader Vladimir Putin had agreed to release diesel supplies into the global market.The corporate earnings test begins next week, with reports due from JPMorgan, Bank of America, Citigroup, Johnson & Johnson, and UnitedHealth.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SpaceXwill acquire a nationwide low-band spectrum license portfolio of up to 14 megahertz of paired spectrum in the 800 MHz band as part of efforts to help Starlink Mobile become a "major mobile carrier" in the U.S.Humanashares jumped while Alignment Healthcareslipped after the Centers for Medicare & Medicaid Services published its 2027 Medicare Part C and Part D Star RatingsDeltareported mixed Q3 results and cut its FY26 earnings outlookApplehas asked some of its suppliers to cut production of components for its iPhone 18 Pro and iPhone 18 Pro Max, Nikkei Asia reportsLumentumCEO Michael Hurlston said the company has "completely sold out" in its optoelectronics parts through nearly 2029, Bloomberg reports2. WALL STREET CALLS:Scotiabank upgraded Webullto Outperform on valuationPershing Squaredowngraded to Sell at Citi after share rallyMonness upgraded Elasticto Buy on agentic AI trendsAlignment Healthcaredowngraded to Neutral at BofAOppenheimer upgraded Fastlyto Outperform on solid industry checks, agentic AI opportunity3. AROUND THE WEB:Hunterbrook is short Meta, saying data show that Muse downloads are slowingCable Oneis close to closing a $1.25B first-lien financing deal, WSJ reportsSouthwestis leaning toward Boeing's787 Dreamliner as its first widebody aircraft to support potential long-haul international expansion, though no final decision has been made and approval rests with the board, Reuters reportsChina-made Teslavehicles were up 5% from a year ago in September, an increase from a 3.6% gain in August, Reuters saysCarlyleis no longer actively pursuing a deal to acquire international assets of Lukoil, Reuters reports4. MOVERS:Quantum-Sigained after announcing it demonstrated detection of 19 amino acids in its Proteus development programGinkgo Bioworksrose after announcing it will provide autonomous lab access to NSF X-Labs researchersModernasurged after the New York Times reported that that NIH is making a big bet on a public-private partnership over cancer vaccinesBrookdale Senior Livingwas lower after announcing occupancy for SeptemberJoby Aviationfell after Barclays downgraded the stock to Underweight5. EARNINGS/GUIDANCE:Braema Hotels & Resortsprovided guidance for FY27Park Aerospacereported Q2 results, with EPS and revenue higher year-over-yearOil-Dri Corporation of Americareported Q4 results, with Daniel Jaffee commenting the company reported its "strongest full year sales" in its historyJPMorganto report Q3 results on October 13Johnson & Johnsonto report Q3 results on October 13INDEXES:The Dow rose 423.31, or 0.83%, to 51,654.95, the Nasdaq gained 172.83, or 0.64%, to 27,366.17, and the S&P 500 advanced 46.18, or 0.59%, to 7,811.54.

10/9 14:30

New Cancer Vaccine Initiative Inspired by COVID Model Launches in December

New details have emerged about a new initiative the starts in December to fast-track cancer vaccines, in which a planned public-private partnership involving the National Institutes of Health, the nonprofit foundation for the NIH, researchers, pharmaceutical and biotech companies, advocacy groups, philanthropies, and patients all working together to work on and test the vaccines, the New York Times' Gina Kolata reports. "We can do things that would not otherwise be done," Dr. Anthony Letai, director of the National Cancer Institute, said of new resources being made available the National Institutes of Health. "We can place big bets on new ideas." "We hope this will be like Covid vaccines," said Stacey Adam, a senior clinical officer at the Foundation for the NIH. The vaccine program is expected to start in December, beginning with a focus on pancreatic cancer, liver cancer, and colorectal cancer, the author notes. Shares of Moderna (MRNA) surged 13.1% after the news, while other pharma and vaccine stocks also traded higher, including Pfizer (PFE), Johnson & Johnson (JNJ), Merck (MRK), Novavax (NVAX), AstraZeneca (AZN), and BioNTech (BNTX).

10/9 10:00

Humana and Others See Notable Gains in Options Trading

Notable gainers among liquid option names this morning include Humana (HUM) $443.94 +56.82, Crown Castle (CCI) $76.25 +7.36, SBA Communications (SBAC) $181.30 +11.29, American Tower (AMT) $177.69 +10.97, and Moderna (MRNA) $205.38 +8.38.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める